A Phase 1/2b Double Blind Randomised Controlled Trial of the Efficacy, Safety and Immunogenicity of Heterologous Prime-boost Immunisation With the Candidate Malaria Vaccines ChAd63 ME-TRAP and MVA ME-TRAP in 5-17 Month Old Burkinabe Infants and Children

Trial Profile

A Phase 1/2b Double Blind Randomised Controlled Trial of the Efficacy, Safety and Immunogenicity of Heterologous Prime-boost Immunisation With the Candidate Malaria Vaccines ChAd63 ME-TRAP and MVA ME-TRAP in 5-17 Month Old Burkinabe Infants and Children

Completed
Phase of Trial: Phase I/II

Latest Information Update: 19 Oct 2016

At a glance

  • Drugs ME-TRAP malaria DNA vaccine Okairos (Primary) ; Rabies vaccine
  • Indications Malaria; Rabies
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Feb 2016 Status changed from recruiting to completed.
    • 01 Nov 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 26 Sep 2012 New source identified and integrated (Pan-African Clinical Trials Registry: PACTR201208000404131).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top